{"name":"Lexeo Therapeutics","slug":"lexeo-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LX1001","genericName":"LX1001","slug":"lx1001","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"LX1001","genericName":"LX1001","slug":"lx1001","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxPTF9kWk8tNnZRZ0F0TGVjZ01CZGdKLTRhTDhQb2l0Qi1PXzl2U3R3ZlREZTFwMHZvWjB2ZFFuc0czVDZXdkcxa2Q4MEVYWG5kVjd4UmlVbk5Db0FweFBXUE1pcE4tYkpnWkNYQ2o0Q2NPa1loOTRETnpEdmJ3S1ZNdEJTS2pGMmlsWjh1WTd1TFNpVGtzZ1lHelA0VzZPOGo4eVJiUE4tN2pYMkJ0cUpwTGV2d19xS25EQWVONDZXWEhsMXBBUTlaWmxuNjlISTdlTWpTa0pkUnpOR0M1ZWRJUXpXQjBrdXE5X1lBeHB6SGFPUEFoRTNxVGRwN3YtRnV2eHA5V1lOWkcyTGhCM2l6ZV96eDZjTGRaaEtWYjZVZFdUS1FaY0Q4TVRiZUg2X19UajdEbmJ0WFBBbXk4Qm1STw?oc=5","date":"2026-04-01","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Bicara Therapeutics Inc. (BCAX) and Compass Therapeutics (CMPX) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Bicara Therapeutics Inc. (BCAX) and Co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNVG1IUEdpNTBPT2Z2cEtPWUJ2X0FKdlJhZFhGa2d1RFFkZDFRU000TThKODVEYW9SdWxKa1VHNG96bDFZSzcyd0U2bWxPd2dLckRfQTdOTXpnSjcwdzQxZEFpNkZjMjVwS0ZBVzNudFJ0cGRzTFd0dlhlSEE1cXFPN0pXUzZTWGhwTUpmLVJOc2prYzhVd3F4Qkg0M2dvNEZ6b3R6Rm13dzl1aVk2SXltUnVRdzU4bEpUOTRfaDVBSF9PX2tBRXhzR0R2TmpRcDU5YlpIUFo4WWE5ZlJNOWE4SWp0bGhlR2JhVGc?oc=5","date":"2026-04-01","type":"deal","source":"The Globe and Mail","summary":"Oppenheimer Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO) - The Globe and Mail","headline":"Oppenheimer Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPdUtvT3FhcVY5V2Fkb2lVV1FBZzVjWnBiWVF6T1BOQnpnU2dpdDdIdGNBUDE1LW12R240dFZ6bXpENWNMTml4YTJ1YkdnT1RXb2ZWakJzMTNUUkptbk9nUGs0bEpoNWtGVmpqVFJLbUkycU0xWUxiZ2pyRl82TFlyaDh4amJIZTlYWlJaVXpFRQ?oc=5","date":"2026-02-13","type":"pipeline","source":"statnews.com","summary":"Up and down the ladder: The latest comings and goings - statnews.com","headline":"Up and down the ladder: The latest comings and goings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOSFVZVnpHbnZQLURBbTZTNVlrLWFjd0ZxY1NvNnJqbXctSE0xM3pKVHNmTXVHZW9VNFVoWkpuQWNwN3BXSjdjcjhZaVJTLXJjMFVQUmhucHlmb1RNQXYtb2xJX01PR2U4OHBXRW84VUxLdWtyald1MmpIOW5JQUhBZFM5Zm4yMkpZN00tY2FqSXEwNEhac2Z2REtyNGRVVzh4Q2xxVkthdw?oc=5","date":"2026-01-30","type":"pipeline","source":"RTTNews","summary":"Lexeo Therapeutics - Revolutionizing Heart Health With Gene Therapies - RTTNews","headline":"Lexeo Therapeutics - Revolutionizing Heart Health With Gene Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOLWp5MmxrWmZhak44Q0hqN2NNUmNYaVZSVGdYT3VhZFhTb0poMHRMZEpqWm93UDM0SDhpeHoxbzliY3g1QUwtTXpVOHQ0OTlKUE1wdi1WVUxLbXZaaUIwS1Q2cEJVYWgzOExNSnp4ZjNkODROcXE0d0c1WEozbTkyY2x0dm8wX1o5R3l4dUJMb3VpQXlGVG5iUFlOaGVSMVdEd3NXeFJMNE4tV25rRzlFbkhJUTZEQWhQ?oc=5","date":"2026-01-30","type":"trial","source":"Endpoints News","summary":"Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeo - Endpoints News","headline":"Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQT1dsLWZZeGdSUm5SVkJZQXRBOXp3ZXZLcDBCaG9nbWh0Z3puYm05N241WDJiemRKODZEZmpRbHhnZG1Bc3loT2QzRXhieTltRzkxOEZtYmVRTVFzdlBDZWlDYmtYRU8yZ01lRTd1N1ZzeHN2dEpVTC13ZVkxNm1aT1JwQXB5aERGOXVzWEZZeHpldXpUVWxrWjExbExaNGtaRGc?oc=5","date":"2026-01-30","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Cardiff churns C-suite to advance cancer candidate - Fierce Biotech","headline":"Chutes & Ladders—Cardiff churns C-suite to advance cancer candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxPdnZxbzhVMHZ4M3Z2NllacDRkRmZTbHFEVEhtb055VVl0TGNoRVdBcFZiNkxCTDZDRGFOckNTMS1BNy1MRFBWWEg2VUc1c2lqNmREMTl2ZEdhRzBraS1CS1BKc3BnSWxQa19Ya3dKQmV6c04xRjhSU2FsVWdoODN0eVhEWFhfSUQwM19NY2hMNFBiV0c0WnlFSkdpcUpwSWpYZUNsdVRxblhoZzdhZ3VNM2NkS29NOVdyeG84eFN0X3NxLTg2aVg0OG9qNmdObmVlcVlOYWVsazI5VnNmLTkwTnZOV1BucnBPUWRxVU10R2Yzb2JXcmU2RjVDWWt6RzVDZ2w5WkVaVUJqM2JlMFUwN2k0bElJOUZxLTBTYWl0SVUtV3Jta2piWUREUGhHb0JnQ3NzU2E1TjFIYXBiSlZhZXB6WDVETV9tOEtfSk52U2lYRzYwOGNmUzNWWlpjR1hQNS1Z?oc=5","date":"2026-01-27","type":"pipeline","source":"globenewswire.com","summary":"Lexeo Therapeutics Announces Key Leadership Appointments - globenewswire.com","headline":"Lexeo Therapeutics Announces Key Leadership Appointments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPMzdMVnJvOGlvZWJwZzRSOUtmVTRCWWlKSE1CUnkyTWQwOC1WRXB1QjBqaklvdk9PMzlHekpBN3ZGLVdBVWYtTjVoSnpqX0ZVV1RON0VramhUel94NGdlQjJRdUstVDBBMzdjUDBuMWhCMGJUeFJFZlBmcXZjRzNKWGdnNElWeWExSkZqRVJIV3VtRnhWc2Uza1lXU1F5YTlYd1lGVUtiWm5DMWZnNXdqTlRIMjNUczRIRE5RQWN3?oc=5","date":"2026-01-08","type":"pipeline","source":"Fierce Biotech","summary":"Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery - Fierce Biotech","headline":"Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxPdWZLcHJ5LWVlVTJPUmFzZ3JyUEE1dXEzLTFfQmRKTFVuRVo2T0hDSUdPQUpobFBtdEg5T2xnZmVzeFdFUlBCMUdvalpFUnZMdjdnSGJyOUM5RmI4bFU1VU9rdnJMZVhVM0ZhNllZdElyUE1LRnlzOTNWVXlvRlpybGFfLVE5RmYzZ2UxbENzVHZOWnkweE05RHVaZXZwSk8wQmpvZjRBZTJjdlFCVE11a1hNVjk1bEI3QWhuV2E2UlljVm5qX2VRQUtzemVmdUZGb2J1TGxYRWRKOUxjV0dDWG5mbXdIcjU0NmJGTFZhelZkU19aZzNwd19OYUJITE5oQXFUR3p6QzNJSi1EV2tXaEFKWDVUUnBCSVZwLUk3eUJfWHdWUXJuNUZVRmp1dGkwZ2twRGROVHM1ZHp5U1M3SFNNTQ?oc=5","date":"2025-12-15","type":"pipeline","source":"PR Newswire","summary":"Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight - PR Newswire","headline":"Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advanc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNa3VvU0E3MFJ0U2VuR1lwLVZpMk41ZTFoZlJOekVIX1UtaFlsSHJReUtYcU04RXVQTjVKNk8xYlppQ2wteTVaeFotU3NreGJQMVJJT3JrM2c0TkVJTkM0NzlYN09Va2xRVjhEMnZPbloxazZjOENNZ19SNmQ4Q1c1eFZ0Q0xiWUJBMjhPVzFVZ3M1MW9MVUl1ZlBINHFXSlpJcGJxaE9TZGtXVUliX3JsVXFHd29xb3NWZVMtMQ?oc=5","date":"2025-10-07","type":"regulatory","source":"BioPharma Dive","summary":"Lexeo says FDA open to speedier approval of rare disease gene therapy - BioPharma Dive","headline":"Lexeo says FDA open to speedier approval of rare disease gene therapy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQcVBkNlJVdGN1RzdzcFFFUXhsX1ZJX2lHMkNHaU9YcUhRRXYzYk4xeUZEZ0dBb09BU3BjT3NXUHRQM1plejNibW5UZ2MtSU1wVzBrZVNXYVdQWU0wUWdnQVpxQzVCd2s0c3FlUzlWWjdGM2FkcjdjZGtLQ2pYYVp6N2d2dG5YOVdnYjhJUkZ2b3QxZw?oc=5","date":"2025-06-24","type":"pipeline","source":"BioPharma Dive","summary":"Lexeo to help launch spinout around RNA drugs for the heart - BioPharma Dive","headline":"Lexeo to help launch spinout around RNA drugs for the heart","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1ZS1JkamhrbUt5cXQwV1E3TUd4YnhYb095eVc1SmR4QTltVWdpRTI4cE9QWHRlZzJKZkVZMTZJZ05uY0ExMmpkMlFNM3NNTm1peXFCWXZGN0xMaGdmYjNoMHdFMk9YYllMUDg3ME5qYVNoYnJqZ2c0?oc=5","date":"2025-05-28","type":"pipeline","source":"The Pharma Letter","summary":"Lexeo raises $80 million to shore up gene therapy work after layoffs - The Pharma Letter","headline":"Lexeo raises $80 million to shore up gene therapy work after layoffs","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}